Banning Therapeutic Cloning Would Be Inhumane
Nathan A. Berger, M.D.
Cleveland
The subject of cloning is rife with emotion, and the Brownback
bill before the Senate is an emotional response that targets all
forms of cloning with highly punitive consequences. This bill fails
to distinguish between cloning that will create another human being
versus cloning that will help treat and cure diseases, such as
Parkinson's, Alzheimer's, diabetes, cancer and spinal cord injuries.
I urge Ohio citizens to contact their senators to ask them to
vote against the Brownback bill, the Human Cloning Prohibition Act
of 2001, S. 1899, and to support S. 2439, a bill sponsored by Sens.
Arlen Specter, Dianne Feinstein, Orrin Hatch and Ted Kennedy, which
would prohibit human reproductive cloning while preserving important
areas of medical research.
Therapeutic cloning, as the name implies, has the potential to
improve the lives of nearly 100 million Americans who suffer from
devastating diseases and conditions.
Therapeutic cloning allows genetic material to be used to develop
advanced stem-cell therapies. These therapies could be tailored to
match each patient's specific medical condition and dramatically
reduce the possibility of the patient's immune system attacking and
rejecting the therapy.
The Brownback bill would prohibit therapeutic cloning and
research cloning. Under it, physicians hoping to relieve patient
suffering and medical researchers attempting to discover cures could
be subject to 10 years in prison and fines of up to $1 million.
The nation's leading scientists, including two prestigious
committees of the National Academy of Sciences and the American
Association of the Advancement of Science, agree that cloning to
reproduce humans should be illegal, but that therapeutic cloning
should be permitted.
The men, women and children who suffer from life-threatening
diseases are engaged in a race against time. It is our
responsibility to make sure that they benefit as quickly as possible
from the very best that science and technology has to offer.
Nathan A. Berger, M.D. is dean of the School of Medicine and
vice president for medical affairs at Case Western Reserve
University.